Surgical treatment of borderline ovarian tumors (case report)
Close
Articolul precedent
Articolul urmator
159 6
Ultima descărcare din IBN:
2024-01-14 10:18
SM ISO690:2012
VÎRLAN, Mariana. Surgical treatment of borderline ovarian tumors (case report). In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 195. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Perspectives of the Balkan medicine in the post COVID-19 era
Ediția 37, 2023
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era"
37, Chişinău, Moldova, 7-9 iunie 2023

Surgical treatment of borderline ovarian tumors (case report)


Pag. 195-195

Vîrlan Mariana
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 26 decembrie 2023


Rezumat

Introduction. Borderline ovarian tumors are non-invasive neoplasms characterized by atypical epithelial proliferation and increased levels of mitotic activity, "on the border" between benign and malignant ovarian tumors. These tumors are usually diagnosed at an early stage and only 25% of cases are in stages II-IV. Their survival is better than that of ovarian cancer, in the early stages being about 83-91% at 10 years. Case report. 28-yearold, nulliparous patient, prophylactic gynecological ultrasonographic examination revealed a 4cm ovarian mass with papillomatous growths, immunologically CA125- 23.2, HE4-75.1, Rome Score 17.9 (N- <11.4). An ovarian mass on the right with suspicion of malignancy is confirmed at resonance. She underwent volume-conservative surgical treatment of ovarian cystectomy on the right side without breaking the tumor capsule, with a biopsy from the peritoneum and omentectomy. Histopathological and immunohistochemical examination: serous borderline ovarian tumor without peritoneal metastases, moderate p53positive, moderate ER-positive, pronounced PRpositive, Ki-67-positive 2%. Dynamically evaluated over 3 and 5 years, she gives birth to two perfectly healthy children with no signs of progression at the moment. Conclusion. The role of conservative treatment for borderline tumors is to preserve the reproductive function of the woman, their evolution is unpredictable, but in cases with favorable evolution is reported, the possibility of ovarian cystectomy instead of adnexectomy and when invasive peritoneal implants are not confirmed, and if the patient wants to preserve her fertility. The prognosis is good, being approximately 83-91% at 10 years, but the recurrence cycle is long.